Development of tetrahydroquinazoline-based Fusion protein inhibitor GZMU04 as a therapeutic candidate against respiratory syncytial virus (RSV)

Mendeley Data 2026 Dataset Open access

Read full text
Authors: Haibin Zhang
DOI: 10.17632/r82nnkntwf
Cited by: 0

Fields of Study & Subjects

Respiratory viral infections research Quinazolinone synthesis and applications SARS-CoV-2 and COVID-19 Research

Publication details

Journal / source
Mendeley Data
Publication date
15 January 2026
Document type
Dataset